Psyence Biomedical (PBM) Treasury Shares (2024 - 2025)

Psyence Biomedical (PBM) recorded quarterly Treasury Shares of $1.5 million in Q3 2025, up 4165.72% quarter-over-quarter from $34731.0 in Q3 2024, and up 4165.72% on a YoY basis from $34731.0 in Q3 2024.

Psyence Biomedical (PBM) Treasury Shares (2024 - 2025) Analysis & Trends

Psyence Biomedical's Treasury Shares history runs 2 years deep, the most recent figure standing at $1.5 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 1.48 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 700,000.00
9 Abivax 94.26 Bn 94.26 Bn - -
10 Regeneron Pharmaceuticals 66.09 Bn 57.33 Bn 3.31 Bn 34.70 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 1.48 Mn
Sep 30, 2025 1.48 Mn
Sep 30, 2024 34,731.00
Sep 30, 2024 34,731.00